Skip to main content
. 2020 Jun 17;319(2):L277–L288. doi: 10.1152/ajplung.00195.2020

Table 1.

Similarities between COVID-19 and pulmonary hypertension

COVID-19 PH
Symptom
    Dyspnea +++ +++
    Fatigue +++ +
Inflammation
    Endotheliitis +++ +*
    Vasculitis +++ +*
    Myocarditis +
    Proinflammatory cytokines ↑↑↑ ↑↑
Thrombosis, microthrombi
    D-dimers ↑↑↑
    Prothrombin
DNA damage
    PARP ↑↑
RAA activation + +++
    ACE 2 ↓↓
    Angiotensin 2 ↑↑↑ ↑↑
Cardiac injury
    Ejection fraction *
    Troponin ↑↑
    Natriuretic peptide ↑↑↑
    RV dilatation ↑↑↑
Pulmonary vascular thickness ↑↑↑
Mitochondrial dysfunction ↑↑
ROS ↑↑
Endothelial dysfunction ↑↑
HPV ↑↑↑§

HPV, hypoxic pulmonary vasoconstriction; PARP, poly-ADP ribose polymerase; PH, pulmonary hypertension; RAA, renin-angiotensin-aldosterone system; ROS, reactive oxygen species; RV, right ventricle.

*

Occasionally;

group 1 pulmonary hypertension;

group 2 pulmonary hypertension;

§

group 3 pulmonary hypertension.

↑ increased, ↑↑ generally increased, ↑↑↑ frequently increased, ↓ decreased, + observed, ++ generally observed, +++, frequently observed.